ISGP Podcast: Regulating Change



Although 20 years of data suggest GMOs do not pose health risks to humans or animals, GMO products remain heavily regulated, inhibiting development. Should regulatory efforts be based on the technology used to create the product, or should they be proportional to the risk posed by the product being evaluated? Debaters weighed in on this and other questions during the debate of the policy paper Regulatory Oversight of New Plant and Animal Varieties in the United States, written by Dr. Alison Van Eenennaam, a biotechnology specialist at University of California, Davis.

The paper was debated at the ISGP conference Production and Sustainability,  held April 2015 in  St. Petersburg, Florida, in partnership with Eckerd College.

For more podcasts, visit ISGP’s The Forum.